| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT
NL NO PL PT RO RS SE SI SK SM TR |
|
Designated Extension States: |
|
BA |
|
Designated Validation States: |
|
KH MA MD TN |
| (30) |
Priority: |
18.08.2022 EP 22191026
|
| (71) |
Applicants: |
|
- ELI LILLY AND CO.
Indianapolis, IN 46285 (US)
- Université d'Aix Marseille
13007 Marseille (FR)
- INSERM (Institut National de la Santé
et de la Recherche Médicale)
75013 Paris (FR)
- CENTRE NATIONAL DE
LA RECHERCHE SCIENTIFIQUE -CNRS-
75016 Paris (FR)
- Institut Jean Paoli & Irène Calmettes
13009 Marseille (FR)
|
|
| (72) |
Inventors: |
|
- ELANDS, Jack
1190 Forest (BE)
- L'HOSPICE, Florence
29770 Primelin (FR)
- PRÉVILLE, Xavier
06330 Roquefort les Pins (FR)
- OLIVE, Daniel
13009 Marseille (FR)
- LOPEZ, Marc
13009 Marseille (FR)
|
| (74) |
Representative: Eli Lilly and Company Limited |
|
8 Arlington Square West
Downshire Way
Bracknell Berkshire RG12 1PU
Bracknell Berkshire RG12 1PU (GB) |
|
